This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Sagard Capital Partners Completes Acquisition Of IntegraMed® America

Sagard Capital Partners, L.P. (“Sagard Capital”) and IntegraMed America, Inc. (NASDAQ: INMD) (“IntegraMed”), a leader in developing, marketing and managing specialty healthcare facilities in the fertility and vein care markets, today announced the completion of Sagard Capital’s acquisition of IntegraMed for $14.05 per share in cash, representing a total equity purchase price of approximately $169.5 million. As a result of the transaction’s completion, IntegraMed’s common stock will cease trading at the close of market today and will be delisted from the NASDAQ Global Market.

Dan Friedberg, Managing Partner of Sagard Capital, said, “We are thrilled to partner with IntegraMed and its impressive team of medical, clinical and administrative personnel. Over the past 25 years, they have built an enviable reputation for providing the highest levels of service to health care facilities that allow for superior patient care, treatment innovation and treatment financing solutions. Sagard is committed to providing IntegraMed’s physician practices, clinics and management with the resources necessary to deliver world-class patient care, to retain and grow top quality partners, and to develop complementary business opportunities. We see a significant opportunity to extend the reach of IntegraMed’s business, bringing its medical specialties to a growing base of patients across the U.S. We look forward to working with the IntegraMed team to support them in building upon their industry leading position and in achieving continued success.”

Jay Higham, CEO and President of IntegraMed, commented, “This is an exciting day for IntegraMed, our patients, physicians and staff as we begin our new partnership with Sagard Capital. As a private company and with the full strategic and financial support of Sagard, IntegraMed is now uniquely positioned to expand the reach of the patient communities we serve. We will also be able to invest aggressively in supporting our physicians and clinic staff to improve the quality of patient care. At the same time, we will continue to explore ways to leverage the IntegraMed model into new areas of specialty and to drive further efficiency into our operations while also bringing innovation to the solutions we provide.”

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,919.59 +80.85 0.48%
S&P 500 1,981.60 +9.86 0.50%
NASDAQ 4,527.5140 +19.2020 0.43%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs